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Silencing of oxidative stress response in mycobacterium
tuberculosis: expression patterns of ahpC in virulent and
avirulent strains and effect of ahpC inactivation
Abstract
Intracellular pathogens such as Mycobacterium tuberculosis are able to survive in the face of
antimicrobial products generated by the host cell in response to infection. The product of the alkyl
hydroperoxide reductase gene (ahpC) of M. tuberculosis is thought to be involved in protecting the
organism against both oxidative and nitrosative stress encountered within the infected macrophage. Here
we report that, contrary to expectations, ahpC expression in virulent strains of M. tuberculosis and
Mycobacterium bovis grown in vitro is repressed, often below the level of detection, whereas expression
in the avirulent vaccine strain M. bovis BCG is constitutively high. The repression of the ahpC gene of
the virulent strains is independent of the naturally occurring lesions of central regulator oxyR. Using a
green fluorescence protein vector (gfp)-ahpC reporter construct we present data showing that repression
of ahpC of virulent M. tuberculosis also occurred during growth inside macrophages, whereas
derepression in BCG was again seen under identical conditions. Inactivation of ahpC on the
chromosome of M. tuberculosis by homologous recombination had no effect on its growth during acute
infection in mice and did not affect in vitro sensitivity to H2O2. However, consistent with AhpC
function in detoxifying organic peroxides, sensitivity to cumene hydroperoxide exposure was increased
in the ahpC::Km(r) mutant strain. The preservation of a functional ahpC gene in M. tuberculosis in spite
of its repression under normal growth conditions suggests that, while AhpC does not play a significant
role in establishing infection, it is likely to be important under certain, as yet undefined conditions. This
is supported by the observation that repression of ahpC expression in vitro was lifted under conditions of
static growth.
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Intracellular pathogens such as Mycobacterium tuberculosis are able to survive in the face of antimicrobial
products generated by the host cell in response to infection. The product of the alkyl hydroperoxide reductase
gene (ahpC) of M. tuberculosis is thought to be involved in protecting the organism against both oxidative and
nitrosative stress encountered within the infected macrophage. Here we report that, contrary to expectations,
ahpC expression in virulent strains of M. tuberculosis and Mycobacterium bovis grown in vitro is repressed, often
below the level of detection, whereas expression in the avirulent vaccine strain M. bovis BCG is constitutively
high. The repression of the ahpC gene of the virulent strains is independent of the naturally occurring lesions
of central regulator oxyR. Using a green fluorescence protein vector (gfp)-ahpC reporter construct we present
data showing that repression of ahpC of virulent M. tuberculosis also occurred during growth inside macro-
phages, whereas derepression in BCG was again seen under identical conditions. Inactivation of ahpC on the
chromosome of M. tuberculosis by homologous recombination had no effect on its growth during acute infection
in mice and did not affect in vitro sensitivity to H2O2. However, consistent with AhpC function in detoxifying
organic peroxides, sensitivity to cumene hydroperoxide exposure was increased in the ahpC::Kmr mutant
strain. The preservation of a functional ahpC gene in M. tuberculosis in spite of its repression under normal
growth conditions suggests that, while AhpC does not play a significant role in establishing infection, it is likely
to be important under certain, as yet undefined conditions. This is supported by the observation that repres-
sion of ahpC expression in vitro was lifted under conditions of static growth.
The success of Mycobacterium tuberculosis as a human
pathogen is based on its ability to survive and grow within
macrophages. Following infection, the bacteria are phagocy-
tosed at the site of entry, usually in the lungs. M. tuberculosis
survives this initial interaction with macrophages and may ei-
ther grow to cause primary tuberculosis or enter a state of
latency in which it can persist, sometimes for decades, within
lung macrophages or other sites. Thus, while it is estimated
that over 1 billion people are infected with M. tuberculosis
worldwide (World Health Organization tuberculosis fact sheet
[http://www.int]), only approximately 5 to 15% of the exposed
individuals who undergo tuberculin conversion develop pri-
mary tuberculosis. The majority remain latently infected and
run a 10% lifetime risk of developing active disease (33, 40).
Latently infected individuals contribute to the persistence of
M. tuberculosis in the population and affect the global tuber-
culosis control efforts. The sequencing and analysis of the
complete M. tuberculosis genome (9) have made possible con-
siderable progress in addressing the molecular basis of myco-
bacterial virulence. However, our understanding of how the
organism survives in the face of hostile innate and acquired
immune responses to produce primary disease and of the mo-
lecular basis for the establishment and maintenance of latency
and for subsequent disease reactivation is far from complete.
M. tuberculosis infects macrophages and persists in granulo-
matous lesions in the host, where the bacilli are exposed to
reactive oxygen intermediates (ROI) (11, 20, 44) and reactive
nitrogen intermediates (6, 18, 26, 28, 30, 35) (RNI). The initial
studies of the oxidative and nitrosative stress response in my-
cobacteria have yielded the paradoxical finding that the oxida-
tive stress response is partially dysfunctional in the two most
important mycobacterial pathogens, M. tuberculosis and Myco-
bacterium leprae (13–15, 27, 48). The M. tuberculosis equivalent
of oxyR (13, 15, 39), the central regulator of the peroxide stress
response (2, 8), which also acts as a regulator of the nitrosative
stress response (21), has been shown to be a pseudogene,
inactivated via multiple lesions (Fig. 1A). Similarly, the furA
and katG genes of M. leprae are vestigial and carry multiple
mutations (9, 14, 27, 32).
Despite the loss of oxyR in M. tuberculosis and inactivation of
furA and katG in M. leprae, several oxidative stress response
genes are preserved in the tubercle and leprosy bacilli. One
such gene, ahpC (9, 13, 23, 39, 48), encodes a subunit of an
enzyme that detoxifies organic peroxides (25, 39) and possibly
hydrogen peroxide (29). AhpC has been implicated in nitric
* Corresponding author. Mailing address: Department of Microbi-
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oxide metabolism using heterologous systems (7). In the ma-
jority of mycobacterial species ahpC is expressed at normal
levels (17, 32, 34, 49). However, the levels of AhpC in M. tu-
berculosis are usually undetectable or very low (17, 46, 51),
although, according to some reports, AhpC can be detected in
the tubercle bacillus (7). In mycobacterial species with a func-
tional oxyR gene, OxyR binds to the ahpC promoter (15, 32,
44). Insertional inactivation of oxyR in Mycobacterium mari-
num results in reduced ahpC expression and abrogates its abil-
ity to respond to induction by exposure to hydrogen peroxide
(Pagan-Ramos and Deretic, unpublished data). These studies
support the notion that the loss of oxyR contributes to the low
expression of ahpC in the tubercle bacillus. Nevertheless, the
preservation of ahpC in M. tuberculosis suggests that, despite
silencing, it plays a role in the physiology of this organism.
Here we extend our investigations of the silencing of ahpC in
M. tuberculosis. We report a second level of ahpC regulation in
the tubercle bacillus and the loss of repression in avirulent
vaccine strain BCG. We also present data on in vivo expression
of ahpC in infected macrophages and on the effect of targeted
deletion of ahpC on the ability of M. tuberculosis H37Rv to
produce acute infection in mice.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and in vivo stability of M. tuberculosis
H37Rv. M. tuberculosis and Mycobacterium bovis strains were from the American
Type Culture Collection unless stated otherwise. Plasmids were introduced into
mycobacteria as previously described (24). The construction and properties of
M. tuberculosis H37Rv*, which overexpresses plasmid-borne ahpC, have been
previously described (17). Mycobacteria were grown under aerated conditions or
in static culture as previously described (45).
Insertional inactivation of ahpC in M. tuberculosis via homologous recombi-
nation. The ahpC gene was inactivated using a previously published strategy for
gene replacements in mycobacteria (36, 37). A BamHI fragment (H37Rv
genomic coordinates 2723977 to 2729394) containing M. tuberculosis ahpC
(cloned on a pBluescript plasmid containing wild-type rpsL from M. tuberculosis;
vector ptrpA-1-rpsL) was subjected to ahpC inactivation with a Kmr cassette by
its insertion into the EcoRI site of ahpC (location 2726263 to 2726460). The
nonreplicative plasmid was introduced into Strr M. tuberculosis H37Rv by elec-
troporation, and Kmr colonies were screened by Southern blot analysis for
single-crossover recombinants. Positively identified strains with the plasmid in-
tegrated on the chromosome via homologous recombination events were sub-
jected to counterselection against rpsL, carried by the vector moiety, by plating
on media containing streptomycin. Strr colonies were subjected to Southern blot
analysis, and recombinants that underwent second crossover events were iden-
tified as strains with ahpC::Kmr gene replacements.
GFP fusions, macrophage infection, flow cytometry, and antibodies for West-
ern blot analyses. The ahpC-gfp and hsp60-gfp fusions and the gfp vector have
been previously reported and characterized (16). Macrophage infection with
mycobacteria passed through a 5-m-pore-size filter to ensure removal of clumps
and flow-cytometric analysis were carried out as previously described (16, 43).
Flow cytometry of formaldehyde-fixed green fluorescence protein (GFP)-labeled
mycobacteria, released from macrophages as described previously (16), was
carried out in a Becton Dickinson FACSCAN, and data were analyzed by Lysis
II software. The rabbit polyclonal antibody raised against purified M. tuberculosis
AhpC has been previously reported (32). The rabbit polyclonal antibody raised
against a KatG peptide was from C. Barry.
Mouse model of tuberculosis infection. The wild-type strain and single-cross-
over and ahpC-deleted mutant strains of M. tuberculosis H37Rv Strr were grown
in Dubos 7H9 broth for 14 days. Each strain was diluted in phosphate-buffered
saline to give a suspension of approximately 2.5  105 CFU per ml, and 0.2 ml
of these suspensions was inoculated intravenously (31) into 6- to 8-week-old
female BALB/c mice. The infection was monitored by removing the lungs and
spleens of infected mice and homogenizing them by shaking with 2-mm-diameter
FIG. 1. (A) Genetic organization of the oxyR-ahpC and furA-katG regions in the M. tuberculosis complex. The M. tuberculosis oxyR pseudogene
(inactivated by multiple mutations; vertical bars) and ahpC are tightly linked and divergently transcribed. The furA and katG genes are linked in
all mycobacteria. The M. bovis BCG furA carries a missense mutation (producing A43V). GFP box preceded by thick line, ahpC-gfp promoter
fusion used in this work. (B) Low or undetectable ahpC expression in virulent M. tuberculosis and M. bovis and high level of AhpC production in
M. bovis BCG. Shown is a Western blot with AhpC antibodies using extracts from various strains of M. tuberculosis (Mt), M. bovis (Mb), and M. bovis
BCG (BCG) grown under standard aerated conditions in roller bottles. Equal amounts of protein were loaded in each lane. The same extracts
tested for KatG showed no differences in all lanes (as in panel D). (C) Multicopy titration of ahpC repression in M. tuberculosis H37Rv. Plasmid
pP/OahpC-oxyR-gfp, carrying the promoter region of ahpC (A), was introduced into M. tuberculosis H37Rv and M. bovis BCG by electroporation,
with selection on media supplemented with antibiotics. Strains were grown under standard, aerated conditions, and cell extracts were examined
by Western blotting using an antibody against M. tuberculosis AhpC (32). (D) Induction of AhpC production in M. tuberculosis H37Rv under static
growth conditions. AhpC levels (Western blot) in M. bovis BCG and M. tuberculosis H37Rv grown under oxygenated (O) and static (S) growth condi-
tions as previously described (45) are shown. Extracts were prepared, and Western blot analysis was carried out with KatG or AhpC antibodies.
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glass beads in chilled saline with a Mini-Bead Beater (Biospec Products, Bartles-
ville, Okla.). Serial 10-fold dilutions of the resultant suspensions were plated
onto Dubos 7H11 agar with Dubos oleic albumin complex supplement (Difco
Laboratories, Surrey, United Kingdom). The numbers of CFU were determined
after the plates had been incubated at 37°C for 20 days.
Sensitivity to compounds and survival in macrophages. Statically grown cul-
tures of H37Rv and H37Rv ahpC::Kmr were allowed to reach stationary phase
(about 3 weeks) in 7H9 broth. One milliliter of each culture was added individ-
ually to 4 ml of 7H9 broth and allowed to settle for 1 week before cumene
hydroperoxide (Sigma Chemicals) or hydrogen peroxide (Sigma Chemicals) was
added at the concentrations indicated in the legend for Fig. 5. The optical density
at 600 nm (OD600) was determined immediately following addition of agents and
on the third and seventh days following treatment.
Statistical analysis. Analysis of variance and post hoc analyses were per-
formed using SuperANOVA (version 1.11; Abacus Concepts).
RESULTS
Low levels of ahpC expression in virulent M. tuberculosis.
Our previous work using antibodies against heterologous AhpC
suggested that levels of AhpC are very low or below detection
limits in M. tuberculosis H37Rv (17). Here we used an antibody
raised against M. tuberculosis AhpC (32) to compare the rela-
tive levels of ahpC expression in different M. tuberculosis
strains. Very low levels of AhpC (or its apparent absence) were
observed in M. tuberculosis strains H37Rv, Erdman, and CSU
#93 (Fig. 1B). Similar silencing of ahpC expression was ob-
served in virulent strain M. bovis Ravenel and the M. bovis type
strain, ATCC 19210 (Fig. 1B). AhpC was detectable in the pre-
viously constructed (17) derivative of M. tuberculosis H37Rv
(termed H37Rv*), which differs from H37Rv only in harboring
a plasmid-borne ahpC gene (Fig. 1B, lane 1).
The very low level of ahpC expression in virulent M. tuber-
culosis complex strains could be attributed to the loss of oxyR
in the tubercle bacillus (12, 14). However, our recent inactiva-
tion of oxyR in M. marinum (Pagan-Ramos and Deretic, un-
published data) has suggested that, while induction of ahpC is
impaired in the oxyR mutant, the steady-state levels of ahpC
remained relatively high and unchanged under normal growth
conditions. Thus, the finding of very low levels of detectable
AhpC in M. tuberculosis was difficult to explain by the loss of
oxyR alone. To test the possibility that this phenomenon could
be due to an additional process of active repression, we intro-
duced into M. tuberculosis H37Rv the ahpC-oxyR intergenic
region containing the ahpC promoter (17) on a plasmid and
examined chromosomal ahpC expression by monitoring AhpC
levels by Western blotting. We detected increased levels of
AhpC in the strain harboring extra copies of the plasmid-borne
ahpC promoter/operator region (Fig. 1C, lanes 1 and 2), indi-
cating that the chromosomal copy of ahpC was derepressed,
possibly due to a multicopy titration of a negative regulatory
element(s), e.g., a transcriptional repressor. These observa-
tions suggest that ahpC may be actively silenced in M. tuber-
culosis via repression mechanisms in addition to the effects of
the loss of activator oxyR. In search of conditions that may
derepress ahpC in virulent strains, we found that growth of
M. tuberculosis H37Rv under static conditions induced produc-
tion of significantly higher levels of AhpC (Fig. 1D, lanes S)
than growth under oxygenated conditions. The effect was spe-
cific for AhpC, as KatG levels did not change (Fig. 1D).
Loss of ahpC repression in avirulent vaccine strain BCG. A
similar set of experiments was carried out with M. bovis BCG
(Pasteur). In contrast to various strains of M. tuberculosis,
M. bovis BCG showed high levels of AhpC expression even in
the absence of the repressor-titrating plasmid construct (Fig.
1C, lane 3), and expression of AhpC was only slightly increased
in the strain harboring the oxyR-ahpC promoter/operator re-
gion. We next investigated different BCG strains and observed
high levels of AhpC (Fig. 1B, lanes 7 to 9) compared to those
for M. tuberculosis (Fig. 1B, lanes 2 to 4). Although levels of
AhpC were relatively high in all BCG strains, they were low or
undetectable in the parent organism, M. bovis (Fig. 1B, lanes 5
and 6). A recent study (3) suggested that BCG Russia (ATCC
35740) is probably the BCG strain that is the closest to the
original strain of BCG derived from virulent M. bovis. BCG
Russia also showed high levels of AhpC (Fig. 1B, lane 7),
suggesting that the deregulation of ahpC expression in BCG is
a property of all BCG strains. Thus, the mutation(s) causing
overexpression of ahpC occurred early in the BCG lineage and
most likely emerged during passages that led to avirulence of
M. bovis BCG.
In vivo silencing of ahpC in M. tuberculosis H37Rv and
expression in M. bovis BCG during macrophage infection. The
experiments described in the previous sections suggest that
ahpC repression in virulent strains may be an important aspect
of M. tuberculosis biology and pathogenesis. However, the
Western blot data were obtained using bacteria cultured in
vitro. To test whether the silencing of ahpC observed in vitro
also takes place in vivo, we examined ahpC expression in in-
fected macrophages using GFP as a reporter of transcriptional
activity (16). M. tuberculosis H37Rv and M. bovis BCG strains
carrying the ahpC-gfp (Fig. 1A) or hsp60-gfp (16) transcrip-
tional fusions were used to infect macrophages. The promoter
activities were monitored by flow cytometry after 3 days of
infection. The results (Fig. 2A and C to E) indicate that, where-
as the hsp60 promoter was active (positive control), the ahpC
promoter was inactive or was expressed below detection limits
in M. tuberculosis H37Rv during macrophage infection. In con-
trast, the activity of the ahpC-gfp fusion in BCG exceeded that
of strong promoter fusion hsp60-gfp (Fig. 2F to H). Hence,
repression (silencing) of ahpC in virulent M. tuberculosis occurs
in vivo during intraphagosomal growth, while ahpC is dere-
pressed in BCG in infected macrophages.
Inactivation of ahpC in M. tuberculosis H37Rv by homolo-
gous recombination and analysis of infection in mice. The
silencing of ahpC during in vitro growth or in infected macro-
phages suggests that AhpC may not play a major role in M. tu-
berculosis in resistance against host-generated protective mecha-
nisms during infection. To test this possibility, we inactivated
the ahpC gene on the chromosome of M. tuberculosis H37Rv
via homologous recombination using a selection procedure
described in Materials and Methods. Southern blot hybridiza-
tion analyses carried out with the parental ahpC strain of
M. tuberculosis H37Rv, single-crossover intermediates, and the
final ahpC::Kmr strain demonstrated that a true gene replace-
ment had taken place (Fig. 3A). Western blot analyses also
confirmed that, while KatG levels were unchanged (Fig. 3B),
there was no detectable AhpC product in the ahpC knockout
strain (Fig. 3C; the protein extracts were prepared from cells
grown under conditions permitting induction of ahpC in M. tu-
berculosis H37Rv as in Fig. 1D).
The mutant ahpC::Kmr strain was then compared with the
parental strain and with the ahpC ahpC::Kmr merodiploid
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single-crossover intermediate strain, which carries both a mu-
tant and wild-type ahpC, for virulence in a mouse model of
tuberculosis. BALB/c mice were infected intravenously with
5 104 CFU of the three strains of M. tuberculosis, and growth
was determined by plating serial dilutions of homogenized
lungs and spleens at 28 and 56 days postinfection. No signifi-
cant difference in growth rate between the mutant ahpC::Kmr
strain and the ahpC strains was observed (Fig. 4). The ap-
parent minor inferiority of the ahpC parental strain was,
however, not seen with the ahpC ahpC::Kmr merodiploid
intermediate, which showed a growth pattern identical to that
of the ahpC mutant. Thus, we conclude that ahpC inactivation
does not reduce the virulence of the tubercle bacillus in the
murine model of tuberculosis.
AhpC role in protection against peroxide toxicity. Despite
the apparent silencing of ahpC in virulent M. tuberculosis, the
preservation of an intact ahpC gene indicates that it confers a
selective advantage under some circumstances encountered by
the organism. The results presented previously (Fig. 1D) indi-
cate that growth of M. tuberculosis under static conditions is
associated with increased expression of ahpC. We therefore
investigated the functional relevance of AhpC production dur-
ing static incubation by exposing the ahpC parental strain of
M. tuberculosis and the isogenic ahpC::Kmr mutant strain to
different concentrations of organic peroxide cumene hydroper-
oxide and hydrogen peroxide under different aeration condi-
tions. In aerated cultures, consistent with low levels of ahpC
expression, no differences in sensitivity to peroxides were de-
tected (data not shown). Under static conditions of growth, we
observed increased sensitivity, specifically to organic peroxide
cumene hydroperoxide, in the ahpC::Kmr mutant compared to
the ahpC  parent (Fig. 5A). No detectable differences be-
tween the wild-type and ahpC::Kmr strains in sensitivity to
hydrogen peroxide were observed (Fig. 5B).
DISCUSSION
The mechanisms by which M. tuberculosis is able to survive
and grow within the hostile environment of a host macrophage
are likely to be complex and multifactorial. In addition to the
ability of the bacteria to influence their microenvironment
within the phagosome (1, 19, 41), the ability of M. tuberculosis
to produce agents which counter the toxicity of antimicrobial
products produced by activated macrophages is thought to be
important. There is considerable evidence that the production
of RNI and/or ROI by macrophages is important in the gen-
eration of effective immunity against mycobacteria (6, 11, 18,
20, 26, 28, 30, 35, 44). Thus, detoxification of RNI and ROI by
the bacteria is expected to influence their intracellular survival.
Several genes in the M. tuberculosis genome which encode
proteins thought to be involved in protection against RNI
and/or ROI have been identified (9). In this study we have
focused on one such gene, ahpC. This gene was chosen because
of its reported role in the virulence of another member of the
M. tuberculosis complex, M. bovis (46), and because of the role
of AhpC in detoxifying organic peroxides (25, 39), hydrogen
peroxide (29), and RNI (4, 7).
Our results with the ahpC::Kmr strain of M. tuberculosis,
which carries an insertionally inactivated ahpC gene, indicate
that AhpC plays no significant role during the acute-infection
FIG. 2. Expression analyses of ahpC in M. tuberculosis H37Rv and
M. bovis BCG in infected macrophages. Expression of ahpC-gfp was
monitored by flow cytometry and compared with that in bacteria car-
rying no gfp (control) and the hsp60-gfp fusion. Macrophages (J774
cells) were infected with mycobacteria containing the gfp fusions indi-
cated, and after 3 days samples were prepared and flow cytometry was
carried out as described previously (16). (A and B) Fluorescence
intensity distribution in macrophage-grown H37Rv and BCG. (C to E)
Dot plots corresponding to panel A. (F to H) Dot plots corresponding
to panel B.
FIG. 3. Inactivation of ahpC in M. tuberculosis H37Rv. (A) South-
ern blot using ahpC as a probe. Two independent isolates in each case
(lanes 2 and 3 and lanes 4 and 5) are shown. (B and C) Western blots
with KatG and AhpC antibodies, respectively. Mycobacteria were grown
under static conditions for Western blot analysis. Equal amounts of
protein were loaded per lane. wt, wild type; sxo, single-crossover strain;
dxo, double-crossover strain.
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phase of mice. This is compatible with similar experiments with
Salmonella enterica serovar Typhimurium, in which inactiva-
tion of ahpC had no effect on virulence in BALB/c mice (42).
Similarly, up-regulation of ahpC in a strain of M. tuberculosis
which had lost KatG activity did not result in increased viru-
lence in mice (22), again suggesting that AhpC is not involved
in virulence, at least during the acute phase of infection. These
results are in contrast to those of Wilson et al. (46), who used
an antisense RNA strategy to down-regulate ahpC expression
in M. bovis and found significantly decreased virulence in
guinea pigs. These discrepancies may be explained by different
methodologies used to generate a null mutant or phenotype,
differences in virulence determinants between M. tuberculosis
and M. bovis in spite of their close sequence similarity, or
different animal models used to evaluate virulence.
Our results demonstrating a very low level of ahpC expres-
sion in M. tuberculosis and M. bovis, contrasting with the high
level of ahpC expression in BCG, both in vitro and during
growth in macrophages, also appear to argue against an overt
role in virulence. Nevertheless, the retention of a functional
ahpC gene by M tuberculosis in spite of the loss of oxyR, the
gene encoding the major regulator of ahpC, suggests that a
functional ahpC must confer some selective advantage. It is
also noteworthy that M. leprae, a closely related pathogen which
has undergone considerable genome downsizing, has retained
functional ahpC and oxyR genes (10). The facts that we found
elevated levels of expression of ahpC in static cultures com-
pared to those in aerated cultures and that in static cultures the
ahpC::Kmr strain of M. tuberculosis was more sensitive to or-
ganic peroxides lend support to the idea that there are envi-
ronmental conditions for which AhpC production is advanta-
geous. Whether such conditions are important during the
infection cycle of M. tuberculosis remains to be determined.
While the lack of a functional oxyR gene in M. tuberculosis
could explain the very low levels of ahpC expression, the reg-
ulation of ahpC in mycobacteria does not appear to simply
involve the binding of OxyR to the ahpC promoter. Introduc-
tion of the plasmid-borne ahpC-oxyR intergenic region results
in increased production of AhpC in M. tuberculosis, consistent
with the presence of a transcriptional repressor. In addition,
M. bovis BCG also lacks oxyR, as is the case with all other
members of the M. tuberculosis complex (12, 14). Thus, differ-
ences in ahpC expression between BCG and virulent M. bovis
cannot be attributed to the loss of oxyR. Overexpression of
ahpC has been associated in some strains of M. tuberculosis and
M. bovis with mutations in the ahpC promoter (17, 38, 51). We
FIG. 4. Effects of ahpC inactivation on M. tuberculosis virulence in mice. BALB/c mice were infected intravenously with 5  104 M. tuberculosis
H37Rv CFU. The numbers of CFU per tissue were determined for spleens (A) and lungs (B). Shown are results from one of the two separate
experiments with similar outcomes (n 6 per time point). Each point represents the mean standard errors. Circles, H37Rv Strr ahpC; triangles,
H37Rv Strr ahpC::Kmr mutant; squares, H37Rv Strr ahpC ahpC::Kmr merodiploid single-crossover strain (ahpC ahpC::Kmr).
FIG. 5. Survival curves of H37Rv and H37Rv ahpC::Kmr treated with cumene hydroperoxide (CHP) (A) or hydrogen peroxide (H2O2) (B).
Percent starting OD600 was determined from the OD600 (see Materials and Methods) normalized to the OD at the beginning of the experiment.
Solid symbols, ahpC strain; open symbols, ahpC::Kmr mutant. wt, wild type.
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determined the nucleotide sequence of the oxyR-ahpC region
in BCG strains, and no sequence alterations in the ahpC pro-
moter were observed to account for the enhanced AhpC levels
in BCG (data not shown). Recently, it has been reported that
ahpC expression is regulated by PerR in gram-positive bacte-
rium Bacillus subtilis (5). Sequence alignments (14, 32) have
indicated that PerR is a close homologue of mycobacterial
FurA, encoded by a gene upstream of katG (Fig. 1). DNA
sequence analyses revealed that all M. bovis BCG strains tested
carry a point mutation (C1283T128) within the furA coding
sequence (GenBank accession no. AF130346 for BCG) rela-
tive to the wild-type sequences in virulent M. bovis strains
(GenBank accession no. AF130347 for the M. bovis type strain,
ATCC 19210) and in all other members of the M. tuberculosis
complex. The C1283T128 change results in the A43V substitu-
tion in BCG FurA (Fig. 1A). The corresponding alanine resi-
due is highly conserved in all FurA homologues, as shown in
multiple sequence alignments of mycobacterial FurA (32), in-
cluding the newly reported Mycobacterium smegmatis FurA
(50). FurA missense mutations in the corresponding regions of
PerR have been found to affect its repressor function and
result in derepression of ahpC in B. subtilis (5). Thus, dere-
pression of ahpC in M. bovis BCG could be the result of the
A43V mutation in the furA gene.
The results reported here demonstrate that M. tuberculosis
regulates expression of AhpC. In spite of the previous failure
to produce a targeted deletion of the ahpC gene in members of
the M. tuberculosis complex (47), ahpC is not an essential gene
for M. tuberculosis, and the protein does not appear to play a
significant role in establishing infection in mice. Nevertheless,
the conservation of a functional ahpC gene, the ability to reg-
ulate its expression, the increased production of the gene prod-
uct during specific conditions of in vitro growth, and its ability
to protect the organism against the toxic activity of organic
peroxides all point to a significant role in the physiology of
M. tuberculosis.
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